Limitations of PIV Biomarker Analysis Related to Chemoradiotherapy and Unadjusted Confounders
The pan-immune-inflammation value (PIV) derived from four blood cell counts warrants cautious interpretation in rectal-cancer immunotherapy, as CRT cannot be disentangled from anti-PD-1 effects within the small n = 16 subgroup.
Authors
- Wencai Weng
- Hongbo Gao
Institutions
- Affiliated Zhongshan Hospital of Dalian University (CN)
Publication Details
- Journal
- Cancer Science
- Published
- 2026-09-17
- DOI
- https://doi.org/10.1111/cas.70543
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00